At Ignyta, we fight cancer – a formidable opponent that manifests as thousands of different molecularly defined diseases and takes away millions of lives globally, every year. In this fight, our vision is not just to shrink tumors but to eradicate residual disease – the source of cancer relapse and recurrence – in precisely defined patient populations by 2030. We will work tirelessly to achieve this vision by pursuing an integrated therapeutic (Rx) and companion diagnostic (Dx) strategy for treating cancer patients. Our Rx efforts are focused on discovering, in-licensing or acquiring, then developing and commercializing, molecularly targeted therapies that, sequentially or in combination, are foundational for eradicating residual disease. Our Dx efforts aim to pair these product candidates with biomarker-based companion diagnostics that are designed to precisely identify, at the molecular level, the patients who are most likely to benefit from the therapies we develop. We believe that only through this integrated Rx/Dx approach can we succeed in this fight.
Show more

Employee Rating

4.1More
TypeSubsidiary
Parent CompanyRoche
HQSan Diego, US
Founded2011
Websiteignyta.com
Ignyta was founded in 2011 and is headquartered in San Diego, US

Viewing summary data as a guest

Sign up for free to see all data

Ignyta Office Locations

Ignyta has an office in San Diego
San Diego, US (HQ)
11095 Flintkote Ave
Show all (1)

Ignyta Financials and Metrics

Summary Metrics

Founding Date

2011
Ignyta is a subsidiary of Roche

Ignyta Revenue

Ignyta's revenue was reported to be $150 k in FY, 2014
Annual
USDFY, 2013Y, 2013FY, 2014FY, 2015FY, 2016

Revenue

150.0k

Revenue growth, %

(100%)

General and administrative expense

3.7m9.5m17.1m23.8m

R&D expense

10.2m30.5m73.5m76.9m
Quarterly
USDQ1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

150.0k

General and administrative expense

1.8m2.0m2.2m3.0m3.9m3.9m5.2m5.5m6.1m5.6m5.5m6.5m

R&D expense

2.2m3.6m8.6m20.2m8.8m10.4m19.8m20.0m16.6m34.0m22.2m21.7m

Operating expense total

3.9m5.6m10.8m23.2m12.7m14.3m25.0m25.5m22.8m39.6m27.7m28.2m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

51.8m6.3m46.4m24.3m

Accounts Receivable

Prepaid Expenses

671.4k1.7m4.4m

Inventories

Quarterly
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(14.2m)(40.0m)(92.5m)(103.6m)

Depreciation and Amortization

112.4k1.4m3.4m3.5m

Accounts Payable

519.6k163.7k2.9m95.0k

Cash From Operating Activities

(13.1m)(32.5m)(50.8m)(90.1m)
Quarterly
USDQ1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(4.0k)(7.5k)(50.4k)(4.1m)(9.5m)(20.2m)(23.5m)(36.6m)(51.2m)(25.5m)(52.1m)(75.4m)(40.2m)(68.4m)(97.0m)

Depreciation and Amortization

48.6k111.7k257.8k724.8k1.3m2.4m1.1m2.4m2.7m803.0k1.6m2.1m

Accounts Payable

2.0k303.5k1.2m(13.7k)869.4k797.1k2.3m5.0m(2.1m)(1.7m)

Cash From Operating Activities

(4.0k)(7.4k)(25.6k)(2.8m)(6.3m)(15.9m)(9.5m)(18.7m)(31.4m)(20.2m)(50.2m)(71.4m)(26.2m)(47.5m)(72.3m)
Show all financial metrics

Ignyta Online and Social Media Presence

Embed Graph

Ignyta Frequently Asked Questions

  • When was Ignyta founded?

    Ignyta was founded in 2011.

  • Who are Ignyta competitors?

    Competitors of Ignyta include Best Doctors, Oxford Immunotec and T2 Biosystems.

  • Where is Ignyta headquarters?

    Ignyta headquarters is located at 11095 Flintkote Ave, San Diego.

  • Where are Ignyta offices?

    Ignyta has an office in San Diego.

  • How many offices does Ignyta have?

    Ignyta has 1 office.